Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A0STSQ8
Tue, 19.11.2024
M1 Kliniken AG
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million
Beauty segment growth driver with sales +33.5% to EUR 71.02 million
EBIT in the Beauty segment +30.4% to EUR 16.26 million
Medium-term target c [ … ]
Fri, 06.09.2024
M1 Kliniken AG
Company Name:
M1 Kliniken AG
ISIN:
DE000A0STSQ8
Reason for the research:
Q2-Bericht
Recommendation:
Kaufen
from:
06.09.2024
Target price:
€28
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) verö [ … ]
Tue, 03.09.2024
M1 Kliniken AG
Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million
Earnings per share increased from EUR 0.17 to EUR 0.53
Beauty segment: sales +30.6% and EBIT +24.3%
Profitable growth to be continued
Berlin, 03.09.2024 – [ … ]
Fri, 21.06.2024
M1 Kliniken AG
M1 Kliniken AG: Management Board confirms growth targets
Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG.
Attila Strauss emphasis [ … ]
Fri, 21.06.2024
M1 Kliniken AG
M1 Kliniken AG: Management Board confirms growth targets
Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG.
Attila Strauss emphasis [ … ]
Tue, 11.06.2024
M1 Kliniken AG
M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
Berlin, 11 June 2024 - Kilian Brenske, member of the Management Board since 2022, has asked the Supervisory Board to terminate his position on the Management Board for private reasons. The areas of national and international expansion, marketing, purchasin [ … ]
Thu, 06.06.2024
M1 Kliniken AG
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 18,00 auf EUR 28,00.
Zusammenfassung:
Die endgültigen Zahlen für 2023 lagen nahe bei den vorläufigen Werten und
bestäti [ … ]
Thu, 06.06.2024
M1 Kliniken AG
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 18,00 auf EUR 28,00.
Zusammenfassung:
Die endgültigen Zahlen für 2023 lagen nahe bei den vorläufigen Werten und
bestäti [ … ]
Thu, 06.06.2024
M1 Kliniken AG
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Group sales increase by 9.6% to EUR 84.7 million in Q1 2024
Growth driver Beauty segment: sales +18.2% and EBIT +50%
Strong operating performance should continue for the rest of the year
Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A [ … ]
Thu, 06.06.2024
M1 Kliniken AG
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Group sales increase by 9.6% to EUR 84.7 million in Q1 2024
Growth driver Beauty segment: sales +18.2% and EBIT +50%
Strong operating performance should continue for the rest of the year
Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A [ … ]